Chronic atrophic gastritis with bleeding
ICD-10 K29.41 is a billable code used to indicate a diagnosis of chronic atrophic gastritis with bleeding.
Chronic atrophic gastritis with bleeding is a condition characterized by the chronic inflammation of the gastric mucosa, leading to the thinning (atrophy) of the stomach lining and potential bleeding. This condition often results from long-term infection with Helicobacter pylori, autoimmune disorders, or prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs). Clinically, patients may present with symptoms such as epigastric pain, nausea, vomiting, and signs of gastrointestinal bleeding, including melena or hematemesis. The anatomy involved primarily includes the stomach, particularly the gastric mucosa, which undergoes pathological changes due to chronic inflammation. Disease progression can lead to complications such as gastric ulcers, anemia from chronic blood loss, and an increased risk of gastric cancer. Diagnostic considerations include endoscopy with biopsy to confirm atrophic changes and rule out malignancy, along with laboratory tests to assess for anemia and H. pylori infection. Early diagnosis and management are crucial to prevent further complications and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K29.41 specifically covers chronic atrophic gastritis that is associated with bleeding. This includes cases where there is evidence of gastric mucosal atrophy and active bleeding, which may be identified through endoscopic findings or clinical symptoms such as hematemesis or melena.
K29.41 should be used when there is clear documentation of chronic atrophic gastritis accompanied by bleeding. If the gastritis is chronic but without bleeding, K29.40 should be selected. Accurate documentation of symptoms and diagnostic findings is essential for appropriate code selection.
Documentation supporting K29.41 should include clinical notes detailing the patient's symptoms, results from endoscopic examinations, biopsy results confirming atrophy, and any laboratory tests indicating anemia or H. pylori infection. Comprehensive treatment plans and follow-up notes are also critical.
